Petros Pharmaceuticals, Inc. (PTPI) stock
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals statistics
25 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 539.6%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Float
- 27M
- 49M
- Shares Held by Insiders
- 35.7%
- 11.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -124.4%
- -49.9%
- Return on Assets (ROA)
- -58.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -484.8%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.25
- 3.30
- Quick Ratio
- 1.23
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$1.07M
- -$689.41K
- Employee Count
- 3
- 74
Income statement (TTM)Industry
- Pretax Income
- -$3.20M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $3.49M
- $17.76M
- Net Cash Per Share
- $0.08
- $0.80
- Equity (Book Value)
- $700.89K
- $53.89M
- Book Value Per Share
- $0.02
- $1.50
- Tangible Book Value
- $700.89K
- $27.13M
- Working Capital
- $700.89K
- $79.99M
Cash flow (TTM)Industry
Scores and fair valueIndustry
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | PTPI | S&P 500 | Difference | PTPI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -28.7% | +0.6% | −29.4 pts | ||
| 3 months | -37.2% | +3.4% | −40.6 pts | ||
| Year to date | -64.2% | +13.3% | −77.4 pts | ||
| 1 year | -87.8% | +16.6% | −104.4 pts | ||
| 3 years | -100.0% | +86.4% | −186.4 pts | -95.8% | +23.1% |
| 5 years | -100.0% | +81.9% | −181.9 pts | -90.7% | +12.7% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M PTPI shares were sold short on Oct 30, 2026, up 47.5% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 56.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 81,660 | +47.5% | 265,467 | 1.0 |
| Oct 15, 2026 | 55,378 | +67.2% | 397,642 | 1.0 |
| Sep 30, 2026 | 33,111 | -71.9% | 128,686 | 1.0 |
| Sep 15, 2026 | 117,772 | +20.5% | 232,797 | 1.0 |
| Aug 31, 2026 | 97,721 | +112.9% | 207,752 | 1.0 |
| Aug 14, 2026 | 45,897 | +5987.1% | 365,847 | 1.0 |
| Jul 31, 2026 | 754 | 0.0% | 106,564 | 1.0 |
| Jul 15, 2026 | 754 | 0.0% | 309,246 | 1.0 |
| Jun 30, 2026 | 754 | 0.0% | 141,078 | 1.0 |
| Jun 15, 2026 | 754 | 0.0% | 210,651 | 1.0 |
| May 29, 2026 | 754 | 0.0% | 131,157 | 1.0 |
| May 15, 2026 | 754 | -98.9% | 205,138 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?